|

CBL0137 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Curaxin

Pipeline

Early 1: 1

Top Sponsors

  • Fox Chase Cancer Center1

Indications

  • Locally Advanced or Metastatic Melanoma1
  • Cancer1

Philadelphia, Pennsylvania1 trial

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Fox Chase Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.